Publication details
Real world data comparing responders and non-responders for natalizumab treatment with using NEDA-3 and annual relapse rate (ARR)
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Appeared in Conference without Proceedings |
| MU Faculty or unit | |
| Citation |